Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer
This study has been completed.
Sponsor:
Introgen Therapeutics
Information provided by:
Introgen Therapeutics
ClinicalTrials.gov Identifier:
NCT00286247
First received: February 1, 2006
Last updated: March 28, 2008
Last verified: March 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |